Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company, today announced that its distribution of cash in September 2012 primarily will be classified as a return of capital to its stockholders for U.S. Federal income tax purposes.
On September 6, 2012, Maxygen distributed approximately $100.0 million in cash to its stockholders. The table below summarizes the U.S. Federal income tax treatment of the distribution for the common stock of Maxygen:
|U.S. Federal Income Tax Treatment|
Distribution Per Maxygen Share ($)
Non-dividend Distribution (Return of Capital)
Maxygen’s tax return for the year ended December 31, 2012 has not been filed. As a result, the tax treatment for the distribution discussed above has been calculated using the best available information as of the date of this release.